Temozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina

Table 1

Main clinical traits of 6 patients with intention-to-treat with temozolomide.

Patient	Sex	Age	Tumor type	Number of previous surgeries	RxT	Previous drug therapy
JB	M	78	PRL Ca	1	Yes	CAB
SA	F	47	CNFPA	3	No	CAB
LC	F	34	GH-oma	2	No	CAB, SSAs
DDO	F	39	NS	2	Yes	None
CM	F	42	CD	1	No	None
GM	F	52	CD	5	Yes	KNZ

PRLCa: prolactin carcinoma; GH-oma: somatotropinoma; CNFPA: clinically nonfunctioning pituitary adenoma; NS: Nelson’ syndrome; CD: Cushing’s disease; RxT: radiotherapy; CAB: cabergoline; SSAs: somatostatin analogs; KNZ: ketoconazole.